Cybin (NYSE American: CYBN) (NEO: CYBN), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment ...

The proposed law would create a regulatory framework for psychadelics' therapeutic use in Massachusetts. But like cannabis, ...

The completion of the Proposed Transaction is subject to the fulfilment, or waiver, of certain conditions, including board approvals, regulatory approvals, a satisfactory due diligence process, and ...

Colorado is making its way through the final regulatory hurdles to launch psychedelic-assisted therapy in 2025. This week, a ...

Providing a diverse range of perspectives from bullish to bearish, 11 analysts have published ratings on MercadoLibre MELI in ...

The centre features six treatment rooms and a group therapy room to support therapy supervision, teaching, and research.

Cybin completed its share consolidation to reduce the number of outstanding shares and drive the value per share higher.

The future of pain medicine is characterized by treatments and technologies — including virtual reality, AI, wearable tech ...

(Alliance News) - Oscillate PLC on Friday said it signed a conditional agreement to fully buy Quantum Hydrogen Inc.

Ernesto Londoño is a national correspondent with The New York Times, where he covers the U.S. midwest. He’s also ...

The pace of innovation and change in the health and medicine space is accelerating wildly, as a broad range of new technologies and scientific discoveries unlock new treatments and therapies we couldn ...

Almost all trials will examine the mechanism of action of psychedelics using the latest developments in neuroimaging, molecular neuroscience, and natural language processing. These initiatives ...